↓ Skip to Main Content
Thasso
Thasso the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs

search: thasso

Log in

Main Navigation

  • english
    • english
    • français
    • deutsch
    • italiano
    • español
    • português
  • thasso
  • thasso post
  • thasso toolbox
    • theragenomics: useful links
    • theragenomics: biomarkers
    • theragenomics: companion tests
    • theragenomics: drug labels with annotated information
    • theragenomics: drugs and genes
    • theragenomics: the world of alleles
    • theragenomics: allele-related guideline information
    • drug interactions
    • drug information
    • drug adverse reactions
    • drugs: risk evaluation and mitigation strategies (REMS)
    • theragenomics: videos
  • thasso academy
    • health authorities
    • patient & consumer health
    • public domain
      • Swiss Academy of Medical Sciences
      • EUPATI The European Patients’ Academy on Therapeutic Innovation
    • companies
    • products
    • about
  • thasso community
    • thasso: simple chat
    • thasso: video chat
    • theragenomics: survey at thasso
      • survey participants
    • forum
      • patient groups / subgroups
      • group
      • lounge
      • events
      • gallery
  • thasso: about
    • vision
    • background
    • the apomediary patient
    • contact
    • disclaimers
    • policies
  • donations
    • thasso – thank you
    • Donation Confirmation

Tag: Immune-Related Adverse Drug Reactions (irADRs)

Cancer therapies: Immune checkpoint inhibitors may kill you

By Joseph Gut - thasso Posted on October 21, 2018 Posted in Adverse Drug Reaction [ADR], New Research, New Safety Information, Thasso Post, Theragenomic Medicine Tagged with Autoimmunity, CTLA-4 Gene, Fatal Adverse Drug Reaction (FADR), Fatal Colitis, Fatal Hepatitis, Fatal Myocarditis, Fatal Neurological Events, Fatal Pneumonitis, French National Alliance for Life and Health Sciences (AVIESAN), Immune Checkpoint Inhibitors (ICI's), Immune-Related Adverse Drug Reactions (irADRs), Ipilimumab [Yervoy], Nivolumab (Opdivo), Pembrolizumab [Keytruda], Programmed Cell Death–1/Ligand-1 (PD-1/PD-L1), Remove term: Fatal Adverse Drug Reaction (FADR) Fatal Adverse Drug Reaction (fADR), Uppsala Monitoring Center (UMC), VigiBase, World Health Organization (WHO)
Cancer therapies: Immune checkpoint inhibitors may kill you

October 21, 2018 – In a study published online September 13 in JAMA Oncology, the authors just reminded us of the fact that besides all hype about immune checkpoint inhibitors (ICIs) in the cancer therapy field, they can be associated with …

Cancer therapies: Immune checkpoint inhibitors may kill you Read more »

Footer Menu

  • english
  • thasso
  • thasso post
  • thasso toolbox
  • thasso academy
  • thasso community
  • thasso: about
  • donations
Copyright © 2025 Thasso | Powered by Responsive Theme